blee03
Gold Member
Google this and pick a link you like... 
WASHINGTON — The U.S. government this week bought $290 million in supplies of a drug designed to treat blood cell injuries following radiological and nuclear emergencies as part of what it said were long-standing efforts to prepare for potential health impacts from threats to national security.
	
		
			
		
		
	
				
			WASHINGTON — The U.S. government this week bought $290 million in supplies of a drug designed to treat blood cell injuries following radiological and nuclear emergencies as part of what it said were long-standing efforts to prepare for potential health impacts from threats to national security.
 
 
		 
 
		 
 
		 
 
		 
					
				 
						
					 
 
		 
 
		